We are excited to announce that Commonwealth Diagnostics International (CDI) is now an approved System for Award Management (SAM.gov) vendor. With our assigned CAGE Code 80GK2, CDI is officially recognized as a trusted partner in the U.S. government procurement system, streamlining our ability to collaborate with federal agencies and deliver diagnostic solutions efficiently.
The SAM.gov platform integrates various government registries to reduce redundancy, lower overhead, and ensure seamless purchasing. This milestone solidifies our commitment to expanding access to accurate, reliable, and non-invasive breath testing for gastrointestinal (GI) health.
In addition to our SAM.gov listing, CDI is proud to be in-network with the Veterans Affairs (VA) Community Care Network (CCN). This partnership allows veterans and their families to access CDI’s hydrogen and methane breath testing services for diagnosing conditions such as Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption disorders.
Our dual alignment with SAM.gov and the VA CCN highlights our dedication to providing exceptional care to a broader range of patients, including those in government-managed healthcare networks. As CDI continues to expand access to its diagnostic offerings, we remain committed to the highest standards of quality, reliability, and service.
CDI’s breath tests are also fully covered for Medicare patients with no balance billing and are now covered as an in-network diagnostic test by a growing list of commercial payors. For more information and an updated insurance coverage list, visit our Billing and Insurance page.
This achievement reflects CDI’s ongoing mission to provide cutting-edge functional GI diagnostic solutions to healthcare providers and patients across various sectors, ensuring both adult GI and pediatric GI patients can access the care they need.
